ADKUDO Trademark

Trademark Overview


On Friday, August 22, 2025, a trademark application was filed for ADKUDO with the United States Patent and Trademark Office. The USPTO has given the ADKUDO trademark a serial number of 99352301. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 17, 2026. This trademark is owned by Corcept Therapeutics Incorporated. The ADKUDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; all of the foregoing excluding pharmaceutical preparations or therapeutic agents administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers
adkudo

General Information


Serial Number99352301
Word MarkADKUDO
Filing DateFriday, August 22, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; all of the foregoing excluding pharmaceutical preparations or therapeutic agents administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorcept Therapeutics Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Party NameCorcept Therapeutics Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events


Event DateEvent Description
Friday, August 22, 2025NEW APPLICATION ENTERED
Friday, August 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 22, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, October 22, 2025ASSIGNED TO EXAMINER
Wednesday, October 22, 2025NON-FINAL ACTION WRITTEN
Wednesday, October 22, 2025NON-FINAL ACTION E-MAILED
Wednesday, October 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025NON-FINAL ACTION WRITTEN
Thursday, October 23, 2025NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 14, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 14, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 14, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 22, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED